Bimatoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. Bimatoprost is manufactured at Cayman Pharma, our Czech subsidiary. The DMF is on file with the US FDA, Canada, and India.